Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,950.00p
   
  • Change Today:
    175.00p
  • 52 Week High: 4,500.00
  • 52 Week Low: 2,350.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 27,211
  • Market Cap: £154.13m
  • Beta: 0.01

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
20.94% below the market average20.94% below the market average20.94% below the market average20.94% below the market average20.94% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average
1yr Revenue Growth
13.23% above the market average13.23% above the market average13.23% above the market average13.23% above the market average13.23% above the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
46.61% above the market average46.61% above the market average46.61% above the market average46.61% above the market average46.61% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
1yr DPS Growth
36.41% below the market average36.41% below the market average36.41% below the market average36.41% below the market average36.41% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
41.02% above the market average41.02% above the market average41.02% above the market average41.02% above the market average41.02% above the market average
48.15% above the sector average48.15% above the sector average48.15% above the sector average48.15% above the sector average48.15% above the sector average
Price Book Ratio
93.93% below the market average93.93% below the market average93.93% below the market average93.93% below the market average93.93% below the market average
74.36% below the sector average74.36% below the sector average74.36% below the sector average74.36% below the sector average74.36% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
29.22% above the market average29.22% above the market average29.22% above the market average29.22% above the market average29.22% above the market average
27.66% above the sector average27.66% above the sector average27.66% above the sector average27.66% above the sector average27.66% above the sector average
Price Chg 3m
24.03% below the market average24.03% below the market average24.03% below the market average24.03% below the market average24.03% below the market average
23.40% above the sector average23.40% above the sector average23.40% above the sector average23.40% above the sector average23.40% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
11.34% above the market average11.34% above the market average11.34% above the market average11.34% above the market average11.34% above the market average
30.23% above the sector average30.23% above the sector average30.23% above the sector average30.23% above the sector average30.23% above the sector average
Momentum 20
95.78% above the market average95.78% above the market average95.78% above the market average95.78% above the market average95.78% above the market average
95.35% above the sector average95.35% above the sector average95.35% above the sector average95.35% above the sector average95.35% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
74.94% above the market average74.94% above the market average74.94% above the market average74.94% above the market average74.94% above the market average
94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average
ROCE
79.84% above the market average79.84% above the market average79.84% above the market average79.84% above the market average79.84% above the market average
38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
90.99% above the market average90.99% above the market average90.99% above the market average90.99% above the market average90.99% above the market average
87.23% above the sector average87.23% above the sector average87.23% above the sector average87.23% above the sector average87.23% above the sector average
Forecast EPS
76.60% above the market average76.60% above the market average76.60% above the market average76.60% above the market average76.60% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
35.6% below the market average35.6% below the market average35.6% below the market average35.6% below the market average35.6% below the market average
Sector averageSector averageSector averageSector averageSector average
Operating Profit Loss
25.70% above the market average25.70% above the market average25.70% above the market average25.70% above the market average25.70% above the market average
78.72% above the sector average78.72% above the sector average78.72% above the sector average78.72% above the sector average78.72% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
24.06% below the market average24.06% below the market average24.06% below the market average24.06% below the market average24.06% below the market average
17.39% above the sector average17.39% above the sector average17.39% above the sector average17.39% above the sector average17.39% above the sector average
Cash
10.02% below the market average10.02% below the market average10.02% below the market average10.02% below the market average10.02% below the market average
8.70% above the sector average8.70% above the sector average8.70% above the sector average8.70% above the sector average8.70% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
76.64% below the market average76.64% below the market average76.64% below the market average76.64% below the market average76.64% below the market average
85.71% below the sector average85.71% below the sector average85.71% below the sector average85.71% below the sector average85.71% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,950.00p
Change Today 175.00p
% Change 6.31 %
52 Week High 4,500.00
52 Week Low 2,350.00
Volume 27,211
Shares Issued 5.22m
Market Cap £154.13m
Beta 0.01

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
15.16% below the market average15.16% below the market average15.16% below the market average15.16% below the market average15.16% below the market average
48.94% above the sector average48.94% above the sector average48.94% above the sector average48.94% above the sector average48.94% above the sector average
Price Trend
63.16% below the market average63.16% below the market average63.16% below the market average63.16% below the market average63.16% below the market average
19.15% below the sector average19.15% below the sector average19.15% below the sector average19.15% below the sector average19.15% below the sector average
Income
43.99% above the market average43.99% above the market average43.99% above the market average43.99% above the market average43.99% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
17.21% below the market average17.21% below the market average17.21% below the market average17.21% below the market average17.21% below the market average
35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 20-May-2025

Time Volume / Share Price
16:35 1,200 @ 2,882.00p
16:25 1,000 @ 2,918.00p
16:25 1,000 @ 2,918.00p
11:31 10,000 @ 2,850.00p
16:42 9,500 @ 2,895.79p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page